133 related articles for article (PubMed ID: 4048170)
1. Mast cells and their degranulation in the Tsk mouse model of scleroderma.
Walker M; Harley R; Maize J; DeLustro F; LeRoy EC
Proc Soc Exp Biol Med; 1985 Nov; 180(2):323-8. PubMed ID: 4048170
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fibrosis in TSK mice by blocking mast cell degranulation.
Walker MA; Harley RA; LeRoy EC
J Rheumatol; 1987 Apr; 14(2):299-301. PubMed ID: 3110419
[TBL] [Abstract][Full Text] [Related]
3. Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma.
Wang HW; Tedla N; Hunt JE; Wakefield D; McNeil HP
Exp Dermatol; 2005 Apr; 14(4):295-302. PubMed ID: 15810888
[TBL] [Abstract][Full Text] [Related]
4. The role of mast cells in the development of skin fibrosis in tight-skin mutant mice.
Everett ET; Pablos JL; Harley RA; LeRoy EC; Norris JS
Comp Biochem Physiol A Physiol; 1995 Feb; 110(2):159-65. PubMed ID: 7704626
[TBL] [Abstract][Full Text] [Related]
5. Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.
Shiota N; Kakizoe E; Shimoura K; Tanaka T; Okunishi H
Br J Pharmacol; 2005 Jun; 145(4):424-31. PubMed ID: 15806109
[TBL] [Abstract][Full Text] [Related]
6. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
[TBL] [Abstract][Full Text] [Related]
7. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
Choi KL; Claman HN
Immunol Ser; 1989; 46():641-51. PubMed ID: 2488873
[No Abstract] [Full Text] [Related]
8. Mast cell numbers in diffuse scleroderma.
Nishioka K; Kobayashi Y; Katayama I; Takijiri C
Arch Dermatol; 1987 Feb; 123(2):205-8. PubMed ID: 3813593
[TBL] [Abstract][Full Text] [Related]
9. Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice.
Kakizoe E; Shiota N; Tanabe Y; Shimoura K; Kobayashi Y; Okunishi H
J Invest Dermatol; 2001 Jan; 116(1):118-23. PubMed ID: 11168806
[TBL] [Abstract][Full Text] [Related]
10. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
11. Ketotifen prevents skin fibrosis in the tight skin mouse.
Walker M; Harley R; LeRoy EC
J Rheumatol; 1990 Jan; 17(1):57-9. PubMed ID: 2313674
[TBL] [Abstract][Full Text] [Related]
12. Dermal mast cell degranulation in systemic sclerosis.
Seibold JR; Giorno RC; Claman HN
Arthritis Rheum; 1990 Nov; 33(11):1702-9. PubMed ID: 2242067
[TBL] [Abstract][Full Text] [Related]
13. Genetic and immunologic features associated with scleroderma-like syndrome of TSK mice.
Saito S; Kasturi K; Bona C
Curr Rheumatol Rep; 1999 Oct; 1(1):34-7. PubMed ID: 11123012
[TBL] [Abstract][Full Text] [Related]
14. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?
Hawkins RA; Claman HN; Clark RA; Steigerwald JC
Ann Intern Med; 1985 Feb; 102(2):182-6. PubMed ID: 3966756
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the concentration of serum anti-topoisomerase I autoantibodies and histological and biochemical alterations in the skin of tight skin mice.
Hatakeyama A; Kasturi KN; Wolf I; Phelps RG; Bona CA
Cell Immunol; 1996 Jan; 167(1):135-40. PubMed ID: 8548837
[TBL] [Abstract][Full Text] [Related]
16. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma-like alterations in collagen metabolism occurring in the TSK (tight skin) mouse.
Jimenez SA; Millan A; Bashey RI
Arthritis Rheum; 1984 Feb; 27(2):180-5. PubMed ID: 6696773
[TBL] [Abstract][Full Text] [Related]
18. A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice.
Ong CJ; Ip S; Teh SJ; Wong C; Jirik FR; Grusby MJ; Teh HS
Cell Immunol; 1999 Aug; 196(1):60-8. PubMed ID: 10486156
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma.
Iwasaki T; Imado T; Kitano S; Sano H
Arthritis Res Ther; 2006; 8(6):R161. PubMed ID: 17049072
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of tsk skin fibrosis to +/+ recipients by tsk bone marrow and spleen cells.
Walker MA; Harley RA; DeLustro FA; LeRoy EC
Proc Soc Exp Biol Med; 1989 Nov; 192(2):196-200. PubMed ID: 2813452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
